Light Clinical Trials

2 recruiting

Frequently Asked Questions

Common questions about Light clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 36 trials

Recruiting
Not Applicable

Feasibility of Light Therapy in the Pediatric Intensive Care Unit (ICU)

Circadian DysregulationLight ExposurePediatric Critical Illness
Laura Beth Kalvas30 enrolled1 locationNCT07384585
Recruiting
Phase 1Phase 2

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

AmyloidosisLight Chain AmyloidosisRelapsed AL Amyloidosis+1 more
Alexion Pharmaceuticals, Inc.91 enrolled18 locationsNCT07081646
Recruiting
Phase 2

BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis

Systemic Light Chain Amyloidosis
Institute of Hematology & Blood Diseases Hospital, China21 enrolled1 locationNCT07151690
Recruiting
Phase 1

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

Relapsed or Refractory Multiple MyelomaPreviously Treated Amyloid Light-chain (AL) Amyloidosis
Janssen Research & Development, LLC180 enrolled29 locationsNCT05652335
Recruiting
Not Applicable

Blue Light for Donor Site Healing in Burn Patients

Donor Site ComplicationBurnPhotobiomodulation Therapy+1 more
AUSL Romagna Rimini25 enrolled1 locationNCT07453927
Recruiting
Not Applicable

Light in Frail Elderly - the Effect of a Dynamic Light for Sleep and Circadian Rhythm

SleepFatigueHumans+9 more
Region Skane300 enrolled1 locationNCT05107947
Recruiting
Phase 1Phase 2

Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients

Systemic Light Chain Amyloidosis
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.70 enrolled23 locationsNCT07266116
Recruiting

Analysis of NfL and GFAP in Different Dietary Patterns

GFAPVegan DietNeurofilament Light Chain+2 more
Salzburger Landeskliniken300 enrolled1 locationNCT07312994
Recruiting
Phase 1Phase 2

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion

Immunoglobulin Light Chain (AL) Amyloidosis
AbbVie76 enrolled21 locationsNCT06158854
Recruiting
Phase 2

3-Month Clinical Trial of Liquid S-PRF in Periodontal Debridement for Periodontitis Stages II-IV

Periodontitis Chronic Generalized ModeratePeriodontitisPeriodontitis (Stage 3)+6 more
Mahsa University14 enrolled1 locationNCT07293962
Recruiting
Phase 2

Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain Amyloidosis

Primary Light-Chain Amyloidosis
Keymed Biosciences Co.Ltd90 enrolled2 locationsNCT07039578
Recruiting

Registry for Adults With Plasma Cell Disorders (PCD's)

Multiple MyelomaAmyloidosisSmoldering Multiple Myeloma+6 more
UNC Lineberger Comprehensive Cancer Center2,000 enrolled1 locationNCT03717844
Recruiting
Not Applicable

Light Therapy on Pain and Synovitis

Knee Pain ChronicLight TherapySynovitis of Knee
The Hong Kong Polytechnic University80 enrolled2 locationsNCT07057063
Recruiting

Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy

Multiple MyelomaAcute Kidney InjuryLight Chain Nephropathy
Brigham and Women's Hospital450 enrolled1 locationNCT06483139
Recruiting
Phase 2

Teclistamab-Daratumumab in AL Amyloidosis

Amyloid Light-chain Amyloidosis
Suzanne Lentzsch, MD25 enrolled1 locationNCT07110844
Recruiting
Not Applicable

Optimizing Light Exposure for Myopia Prevention and Control (LightSPAN)

MyopiaMyopia; Refractive ErrorMyopia Progression+2 more
National University of Singapore396 enrolled5 locationsNCT06631339
Recruiting
Phase 1Phase 2

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

Relapsed/Refractory Systemic Light Chain Amyloidosis
Regeneron Pharmaceuticals220 enrolled18 locationsNCT06292780
Recruiting
Phase 1Phase 2

Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis

Light Chain (AL) Amyloidosis
Nexcella Inc.40 enrolled18 locationsNCT06097832
Recruiting
Not Applicable

Assessing the Efficacy of Photodynamic Therapy for Preventing Surgical Site Infections

SurgeryLight; Therapy, ComplicationsNasal Disease
Guy's and St Thomas' NHS Foundation Trust80 enrolled1 locationNCT06731881
Recruiting
Not Applicable

Light Timing Study

SleepCircadian RhythmAdolescence+2 more
Rush University Medical Center113 enrolled1 locationNCT04753190